Company page

Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited, trading under the ticker RGC, is a public company operating in the American market. With a market capitalization of approximately $5.95 billion, Regencell focuses on developing innovative bioscience solutions. The company is dedicated to advancing its research and product offerings in the bioscience sector.

profileRGC:NASDAQAI content: aiUpdated June 24, 2026/company/regencell-bioscience-holdings-ltd/c-tjhihcjr
Regencell Bioscience Holdings Limited logo
Ticker
RGC:NASDAQ
Asset type
Stock
Market cap
$5.95B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD